Financial Instruments - Additional Information (Detail) shares in Millions, $ in Millions, £ in Billions |
1 Months Ended |
12 Months Ended |
|
|
|
May 31, 2025
USD ($)
|
May 31, 2025
CAD ($)
|
Mar. 31, 2025 |
Dec. 31, 2024
USD ($)
|
Sep. 30, 2024
USD ($)
|
Dec. 31, 2025
USD ($)
Basispoint
|
Dec. 31, 2024
USD ($)
shares
|
Dec. 31, 2024
CAD ($)
|
Dec. 31, 2024
GBP (£)
|
Dec. 31, 2023
USD ($)
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Borrowings |
|
|
|
$ 2,820,000,000
|
|
$ 2,123,000,000
|
$ 2,820,000,000
|
|
|
|
| Other financial liabilities, non-current |
|
|
|
0
|
|
$ 16,000,000
|
0
|
|
|
|
| Derivatives hedge ratio |
|
|
|
|
|
1:1
|
|
|
|
|
| Solicitation fees |
|
|
|
|
|
$ 4,000,000
|
|
|
|
|
| Transaction costs |
|
|
|
|
|
8,000,000
|
|
|
|
|
| Cash collateral |
|
|
|
0
|
|
7,000,000
|
0
|
|
|
|
| Proceeds from (payment to) settlement of foreign exchange contracts |
|
|
|
|
|
|
24,000,000
|
|
|
|
| Losses on change in fair value of derivatives |
|
|
|
|
|
(8,000,000)
|
99,000,000
|
|
|
|
| Foreign currency translation adjustments to OCI |
|
|
|
|
|
$ 269,000,000
|
(173,000,000)
|
|
|
|
| Percentage strengthening of US dollar against other foreign currencies |
|
|
|
|
|
10.00%
|
|
|
|
|
| Cash and cash equivalents |
|
|
|
1,968,000,000
|
|
$ 511,000,000
|
1,968,000,000
|
|
|
$ 1,298,000,000
|
| Short-term Investments, cash and cash equivalents |
|
|
|
1,095,000,000
|
|
$ 235,000,000
|
1,095,000,000
|
|
|
|
| Percentage of cash and cash equivalents held by a rated institutions |
|
|
|
|
|
96.00%
|
|
|
|
|
| Trade and other receivables |
|
|
|
1,087,000,000
|
|
$ 1,143,000,000
|
1,087,000,000
|
|
|
|
| Other financial assets |
|
|
|
378,000,000
|
|
392,000,000
|
378,000,000
|
|
|
|
| Gross loan commitments |
|
|
|
|
|
2,000,000,000
|
|
|
|
|
| Due from indemnification arrangement |
|
|
|
272,000,000
|
|
288,000,000
|
272,000,000
|
|
|
|
| Other receivables |
|
|
|
29,000,000
|
|
32,000,000
|
29,000,000
|
|
|
|
| Financial assets at fair value through other comprehensive income |
|
|
|
99,000,000
|
|
168,000,000
|
99,000,000
|
|
|
|
| Cash consideration received on disposal of business |
|
|
|
|
|
254,000,000
|
326,000,000
|
|
|
|
| Derivative financial liabilities |
|
|
|
21,000,000
|
|
16,000,000
|
21,000,000
|
|
|
|
| Level 3 [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Short-term Investments, cash and cash equivalents |
|
|
|
0
|
|
0
|
0
|
|
|
|
| Financial assets at fair value through other comprehensive income |
|
|
|
98,000,000
|
|
168,000,000
|
98,000,000
|
|
|
|
| Increase in financial assets at fair value through other comprehensive income |
|
|
|
|
|
46,000,000
|
|
|
|
|
| Contingent Receivables [Member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Other receivables |
|
|
|
88,000,000
|
|
84,000,000
|
88,000,000
|
|
|
|
| Cash consideration received on disposal of business |
|
|
|
88,000,000
|
|
|
|
|
|
|
| Thomson Reuters Corporation [Member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Proportion of ownership interest in subsidiary |
|
|
100.00%
|
|
|
|
|
|
|
|
| At fair value [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Derivative financial liabilities |
|
|
|
21,000,000
|
|
16,000,000
|
21,000,000
|
|
|
|
| Other finance income [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Losses on change in fair value of derivatives |
|
|
|
|
|
|
2,000,000
|
|
|
|
| Fixed-to-floating interest rate swaps [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Other financial liabilities, non-current |
|
|
|
|
|
$ 16,000,000
|
|
|
|
|
| Fixed-to-floating interest rate swaps notional amount |
|
|
|
|
|
410,000,000
|
|
|
|
|
| Cash collateral |
|
|
|
|
|
$ 7,000,000
|
|
|
|
|
| Losses on change in fair value of derivatives |
|
|
|
|
|
16,000,000
|
0
|
|
|
|
| Foreign exchange contracts settlement [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Derivative financial assets |
|
|
|
0
|
|
$ 0
|
0
|
|
|
|
| Notional amount |
|
|
|
1,600,000,000
|
|
|
1,600,000,000
|
|
£ 1.2
|
|
| Proceeds from (payment to) settlement of foreign exchange contracts |
|
|
|
|
|
|
$ 24,000,000
|
|
|
|
| Foreign exchange contracts settlement [member] | LSEG [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares sold that relate to company ownership | shares |
|
|
|
|
|
|
16.0
|
|
|
|
| Interest rate risk [member] | SOFR [Member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Percentage of reasonably possible increase in unobservable input, assets | Basispoint |
|
|
|
|
|
100
|
|
|
|
|
| Percentage of reasonably possible decrease in unobservable input assets | Basispoint |
|
|
|
|
|
100
|
|
|
|
|
| Increase decrease in fair value measurement due to reasonably possible increase in unobservable inputs recognized in profit or loss before tax assets |
|
|
|
|
|
$ 4,000,000
|
|
|
|
|
| Interest rate risk [member] | Interest bearing assets [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Short-term Investments, cash and cash equivalents |
|
|
|
|
|
$ 235,000,000
|
|
|
|
|
| Percentage of reasonably possible increase in unobservable input, assets | Basispoint |
|
|
|
|
|
100
|
|
|
|
|
| Percentage of reasonably possible decrease in unobservable input assets | Basispoint |
|
|
|
|
|
100
|
|
|
|
|
| Increase decrease in fair value measurement due to reasonably possible increase in unobservable inputs recognized in profit or loss before tax assets |
|
|
|
|
|
$ 2,000,000
|
|
|
|
|
| Credit risk [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Cash and cash equivalents |
|
|
|
1,968,000,000
|
|
511,000,000
|
$ 1,968,000,000
|
|
|
|
| Trade and other receivables |
|
|
|
$ 1,087,000,000
|
|
$ 1,143,000,000
|
$ 1,087,000,000
|
|
|
|
| 3.85% Notes, due 2024 [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Borrowings |
|
|
|
|
$ 450,000,000
|
|
|
|
|
|
| Borrowings, interest rate |
|
|
|
|
3.85%
|
|
|
|
|
|
| Repayments of current borrowings |
|
|
|
|
$ 242,000,000
|
|
|
|
|
|
| 2.239% Notes, due 2025 [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Borrowings, interest rate |
2.239%
|
2.239%
|
|
2.239%
|
|
|
2.239%
|
2.239%
|
2.239%
|
|
| Notional amount |
|
|
|
|
|
|
|
$ 1,400
|
|
|
| Maturity date |
|
|
|
|
|
|
2025
|
|
|
|
| Repayments of current borrowings |
$ 999,000,000
|
$ 1,400
|
|
|
|
|
|
|
|
|
| Derivative financial liabilities |
|
|
|
$ 21,000,000
|
|
|
$ 21,000,000
|
|
|
|
| 2.239% Notes, due 2025 [member] | At fair value [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Derivative financial liabilities |
|
|
|
$ 21,000,000
|
|
|
$ 21,000,000
|
|
|
|
| 4.50% Notes, due 2043 [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Borrowings, interest rate |
|
|
|
4.50%
|
|
4.50%
|
4.50%
|
4.50%
|
4.50%
|
|
| Notional amount |
|
|
|
$ 119,000,000
|
|
$ 119,000,000
|
$ 119,000,000
|
|
|
|
| Maturity date |
|
|
|
|
|
2043
|
2043
|
|
|
|
| Derivative financial liabilities |
|
|
|
0
|
|
$ 3,000,000
|
$ 0
|
|
|
|
| 4.50% Notes, due 2043 [member] | At fair value [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Derivative financial liabilities |
|
|
|
$ 0
|
|
$ 3,000,000
|
$ 0
|
|
|
|
| 4.50% Notes, due 2043 [member] | Fixed-to-floating interest rate swaps [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Borrowings, interest rate |
|
|
|
|
|
4.50%
|
|
|
|
|
| Notional amount |
|
|
|
|
|
$ 119,000,000
|
|
|
|
|
| Fixed-to-floating interest rate swaps notional amount |
|
|
|
|
|
80,000,000
|
|
|
|
|
| Maturity date |
|
|
|
|
|
May 2043
|
|
|
|
|
| 5.65% Notes, due 2043 [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Borrowings, interest rate |
|
|
|
5.65%
|
|
5.65%
|
5.65%
|
5.65%
|
5.65%
|
|
| Notional amount |
|
|
|
$ 350,000,000
|
|
$ 350,000,000
|
$ 350,000,000
|
|
|
|
| Maturity date |
|
|
|
|
|
2043
|
2043
|
|
|
|
| Derivative financial liabilities |
|
|
|
0
|
|
$ 13,000,000
|
$ 0
|
|
|
|
| 5.65% Notes, due 2043 [member] | At fair value [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Derivative financial liabilities |
|
|
|
0
|
|
$ 13,000,000
|
0
|
|
|
|
| 5.65% Notes, due 2043 [member] | Fixed-to-floating interest rate swaps [member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Borrowings, interest rate |
|
|
|
|
|
5.65%
|
|
|
|
|
| Notional amount |
|
|
|
|
|
$ 350,000,000
|
|
|
|
|
| Fixed-to-floating interest rate swaps notional amount |
|
|
|
|
|
330,000,000
|
|
|
|
|
| Maturity date |
|
|
|
|
|
November 2043
|
|
|
|
|
| Commercial Paper [Member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Borrowings |
|
|
|
0
|
|
$ 295,000,000
|
0
|
|
|
|
| Commercial paper programs |
|
|
|
|
|
2,000,000,000
|
|
|
|
|
| Amended Credit Facility Maturities In November 2030 [Member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Borrowings |
|
|
|
$ 0
|
|
0
|
$ 0
|
|
|
|
| Gross loan commitments |
|
|
|
|
|
$ 2,000,000,000
|
|
|
|
|
| Basis point adjustment to reference interest rate |
|
|
|
|
|
9.2
|
|
|
|
|
| Additional commitment from lenders |
|
|
|
|
|
$ 600,000,000
|
|
|
|
|
| Maximum credit facility agreement |
|
|
|
|
|
2,600,000,000
|
|
|
|
|
| Purchase price |
|
|
|
|
|
$ 500,000,000
|
|
|
|
|
| Net debt to adjusted EBITDA |
|
|
|
|
|
0.6
|
|
|
|
|
| Amended Credit Facility Maturities In November 2030 [Member] | Top of Range [Member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Required ratio of net debt to ebitda |
|
|
|
|
|
4.5
|
|
|
|
|
| Amended Credit Facility Maturities In November 2030 [Member] | Scenario Forecast [Member] |
|
|
|
|
|
|
|
|
|
|
| Disclosure of detailed information about financial instruments [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Required ratio of net debt to ebitda |
|
|
|
|
|
5
|
|
|
|
|